Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00083577
Recruitment Status : Completed
First Posted : May 27, 2004
Last Update Posted : July 2, 2010
Sponsor:
Information provided by:
University of Arkansas

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Primary Completion Date : No date given
Study Completion Date : May 2005